Animal only

KPV

Gut inflammation in laboratory cells and mouse models. A published human trial has not been shown.

15-second reel. It plays silently on a loop.

What it is

KPV is a three-amino-acid peptide, the C-terminal end of the hormone alpha-MSH (lysine-proline-valine). The research question people bring to it is gut inflammation. The reel says it in one line — a short peptide studied for gut inflammation in the lab. Mouse and lab studies. Not tested as a treatment in people.

Studied for

  • Inflammatory signaling in cultured human gut and immune cells.
  • Chemically induced colitis in mouse models.
  • Uptake through the intestinal peptide transporter PepT1, as a laboratory mechanism, not a demonstrated effect in patients.

The evidence

Animal only. In the lab, KPV reduced inflammatory signals in cultured human gut and immune cells. In mice, it reduced chemically induced colitis in several models. Those are laboratory and animal findings, not a trial in people with inflammatory bowel disease. A published human study giving KPV to people has not been shown. This is not an FDA-approved medicine.

What this page will not do

  • “Studied for gut inflammation” on the reel is the research question. It is not a result we are claiming in people.
  • We do not give a dose, a route, a cycle, or a place to buy it.
  • Work on human cells in a dish is not a human trial.

Still open

  • Whether a controlled human study, with a stated size and duration, gets published.
  • How chemically induced colitis in mice should be weighed against human inflammatory bowel disease. Our answer: as a hypothesis, not a result in people.

Educational content only. This page does not diagnose, treat, cure, or prevent anything, and it is not a dose. Talk with a licensed physician before starting, stopping, or changing any medication. Library reviewed November 2026.